CoChat

MD‐Logic overnight type 1 diabetes control in home settings: Amulticentre, multinational, single blind randomized trial

Nimri, Revital, Bratina, Natasa, Kordonouri, Olga, Avbelj Stefanija, Magdalena, Fath, Maryam, Biester, Torben, Muller, Ido, Atlas, Eran, Miller, Shahar, Fogel, Aviel, Phillip, Moshe, Danne, Thomas, Battelino, Tadej · 2017 · Diabetes, Obesity and Metabolism
Cited by 42

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Aims: To evaluate the safety, efficacy and need for remote monitoring of the MD‐L ogic closed‐loop system during short‐term overnight use at home. Methods: Seventy‐five patients (38 male; aged 10‐54 years; average A1c, 7.8% ± 0.7%, 61.8 ± 7.2 mmol/mol) were enrolled from 3 clinical sites. Patients were randomly assigned to participate in 2 overnight crossover periods, each including 4 consecutive nights, 1 under closed‐loop control and 1 under sensor‐augmented pump ( SAP ) therapy in the patient's home. Both study arms were supervised using a remote‐monitoring system in a blinded manner. Primary endpoints were time spent with glucose levels below 70 mg/d L and percentage of nights in which mean overnight glucose levels were within 90 to 140 mg/d L . Results: The median [interquartile range] percentage of time spent in hypoglycaemia was significantly lower on nights when MD‐L ogic was used, compared to SAP therapy (2.07 [0, 4.78] and 2.6 [0, 10.34], respectively; P = .004) and the percentage of individual nights with a mean overnight glucose level in target was significantly greater (75 [42, 75] and 50 [25,75], respectively; P = .008). The time spent in target range was increased by a median of 28% ( P = .001), with the same amount of insulin (10.69 [7.28, 13.94] and 10.41[6.9, 14.07], respectively; P = .087). The remote monitoring triggered calls for hypoglycaemia at twice the rate during SAP therapy compared to closed‐loop control (62 and 29, respectively; P = .002). Conclusions: The MD‐L ogic system demonstrated a safe and efficient profile during overnight use by children, adolescents and adults with type 1 diabetes and, therefore, provides an effective means of mitigating the risk of nocturnal hypoglycaemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12852

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 42

Metadata

Authors
Nimri, R., Bratina, N., Kordonouri, O., Avbelj Stefanija, M., Fath, M., Biester, T., Muller, I., Atlas, E., Miller, S., Fogel, A., Phillip, M., Danne, T., & Battelino, T.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2017-01-19
Volume
19
Issue
4
Pages
553-561
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2564924912
Cited by
42
References
6
FWCI
4.91
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.